TIDMINS
RNS Number : 7242L
Instem plc
05 January 2023
Instem plc
("Instem" or "the Company")
Exercise of Options, Director/PDMR Dealing and Total Voting
Rights
Instem plc (AIM: INS), a leading provider of IT solutions to the
global life sciences market, announces that it was notified on 4
January 2023 that certain of the Company's Directors and members of
its senior management team exercised share options ("Share
Options") over, in aggregate, 61,404 ordinary shares of 10 pence
each in the Company ("Ordinary Shares"). The Share Options were
exercised on 4 January 2023 at an exercise price of GBP0.90 per
Ordinary Share. The Share Options were granted on 14 January 2013
and would have lapsed if not exercised before 14 January 2023.
Subsequently, also on 4 January 2023, certain Directors sold the
Ordinary Shares issued on the exercise of Share Options in their
entirety at a price of GBP7.00 per Ordinary Share.
Details of the Directors (each of whom is a person discharging
managerial responsibility or "PDMR") who exercised Share Options
and subsequently sold Ordinary Shares are as follows:
Director No. Share No. Ordinary Resultant Resultant
Options exercised Shares sold interest interest
in Ordinary in Ordinary
Shares Shares as
a % of ISC
Phil Reason, CEO 23,429 23,429 770,714 3.39%
Nigel Goldsmith,
CFO 15,000 15,000 10,000 0.04%
Issue of Equity and Admission
Application will be made to the London Stock Exchange for the
admission of the 61,404 new Ordinary Shares to trading on AIM ("New
Ordinary Shares"). Admission is expected to take place at 8.00 a.m.
on 10 January 2023.
Total voting rights
Following the issue and allotment of the above New Ordinary
Shares, the Company's issued share capital comprises 22,765,712
Ordinary Shares. The Company does not hold any Ordinary Shares in
treasury. Therefore the total number of voting rights in the
Company is 22,765,712.
The figure of 22,765,712 may be used by shareholders as the
denominator for the calculations by which they will determine if
they are required to notify their interest in, or a change of their
interest in, the Company under the FCA's Disclosure Guidance and
Transparency Rules.
For further information, please contact:
Instem plc via Walbrook
Singer Capital Markets (Nominated Adviser
& Joint Broker) +44 (0) 20 7496 3000
Peter Steel
Alex Bond
Oliver Platts
Stifel Nicolaus Europe Limited (Joint
Broker) +44 (0) 20 7710 7600
Ben Maddison
Alex Price
Walbrook Financial PR +44 (0) 20 7933 8780
Tom Cooper instem@walbrookpr.com
Nick Rome
About Instem
Instem is a leading provider of IT solutions & services to
the life sciences market delivering compelling solutions for Study
Management, Regulatory Submissions, Clinical Trial Acceleration,
and Informatics-based Insight Generation.
Instem solutions are in use by over 700 customers worldwide,
including all of the largest 25 pharmaceutical companies, enabling
clients to bring life enhancing products to market faster. Instem's
portfolio of software solutions increases client productivity by
automating study-related processes while offering the unique
ability to generate new knowledge through the extraction and
harmonisation of actionable scientific information.
Instem products and services address aspects of the entire drug
development value chain, from discovery through to market launch.
Management estimate that over 50% of all drugs on the market have
been through some part of Instem's platform during their
development.
To learn more about Instem solutions and its mission, please visit www.instem.com
Notification and public disclosure of transactions by persons
discharging managerial responsibilities ("PDMRs") and persons
closely associated with them
The information set out below is provided in accordance with the
requirements of Article 19(3) of the EU Market Abuse Regulation No
596/2014.
1 Details of the person discharging managerial
responsibilities / person closely associated
a) Name Phil Reason
------------------------- ------------------------------------------
2 Reason for the notification
---------------------------------------------------------------------
a) Position/status CEO
------------------------- ------------------------------------------
b) Initial notification Initial
/Amendment
------------------------- ------------------------------------------
3 Details of the issuer, emission allowance market
participant, auction platform, auctioneer or auction
monitor
---------------------------------------------------------------------
a) Name Instem plc
------------------------- ------------------------------------------
b) LEI 213800PILYUFNNROQX68
------------------------- ------------------------------------------
4 Details of the transaction(s): section to be
repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and
(iv) each place where transactions have been conducted
---------------------------------------------------------------------
a) Description of Ordinary shares of 10p each
the financial
instrument, type
of instrument
Identification GB00B3TQCK30
code
b) Nature of the 1. Exercise of Options
transaction 2. Sale of Ordinary Shares
------------------------- ------------------------------------------
c) Price(s) and
volume(s)
-------------------------- -----------
Price Volume(s)
-------------------------- -----------
1. 90p per
Ordinary
Share (exercise
price) 23,429
--------------------------------------------------------- -----------
2. 700p per
Ordinary
Share (sale
price) 23,429
--------------------------------------------------------- -----------
d) Aggregated information n/a - the exercise of options
over Ordinary Shares and the sale
of Ordinary Shares each completed
as single transactions
- Aggregated
volume
- Price
e) Date of the transaction 4 January 2023
------------------------- ------------------------------------------
f) Place of the In respect of the exercise of
transaction options over Ordinary Shares:
outside a trading venue
In respect of the sale of Ordinary
Shares: London Stock Exchange,
AIM Market (XLON)
------------------------- ------------------------------------------
1 Details of the person discharging managerial
responsibilities / person closely associated
a) Name Nigel Goldsmith
------------------------- ------------------------------------------
2 Reason for the notification
---------------------------------------------------------------------
a) Position/status CFO
------------------------- ------------------------------------------
b) Initial notification Initial
/Amendment
------------------------- ------------------------------------------
3 Details of the issuer, emission allowance market
participant, auction platform, auctioneer or auction
monitor
---------------------------------------------------------------------
a) Name Instem plc
------------------------- ------------------------------------------
b) LEI 213800PILYUFNNROQX68
------------------------- ------------------------------------------
4 Details of the transaction(s): section to be
repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and
(iv) each place where transactions have been conducted
---------------------------------------------------------------------
a) Description of Ordinary shares of 10p each
the financial
instrument, type
of instrument
Identification GB00B3TQCK30
code
b) Nature of the 1. Exercise of Options
transaction 2. Sale of Ordinary Shares
------------------------- ------------------------------------------
c) Price(s) and
volume(s)
-------------------------- -----------
Price Volume(s)
-------------------------- -----------
1. 90p per
Ordinary
Share (exercise
price) 15,000
--------------------------------------------------------- -----------
2. 700p per
Ordinary
share (sale
price) 15,000
--------------------------------------------------------- -----------
d) Aggregated information n/a - the exercise of options
over Ordinary Shares and the sale
of Ordinary Shares each completed
as single transactions
- Aggregated
volume
- Price
e) Date of the transaction 4 January 2023
------------------------- ------------------------------------------
f) Place of the In respect of the exercise of
transaction options over Ordinary Shares:
outside a trading venue
In respect of the sale of Ordinary
Shares: London Stock Exchange,
AIM Market (XLON)
------------------------- ------------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHUPUPCGUPWGMC
(END) Dow Jones Newswires
January 05, 2023 02:00 ET (07:00 GMT)
Instem (LSE:INS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Instem (LSE:INS)
Historical Stock Chart
From Jul 2023 to Jul 2024
